Innovation in Personalized Medicine & Population Health Speaker Series

Exploring Emerging Solutions Through Multi-Cancer Early Detection

Multi-Cancer Early Detection (MCED) is an emerging set of technologies that, when added to existing single cancer screening, offer an opportunity to identify a broad range of cancers earlier in the course of disease.

This paves the way for a paradigm shift in cancer detection by screening the broader population for up to 50 cancers at once.

In 2021, Jefferson College of Population Health hosted a series of informational webinars devoted to the important issues associated with this innovation. Based on the response to the series, JCPH is offering a limited number of on-demand sessions.

Program Overview

The Professonal Development team at JCPH will work with you to plan a customized educational session exploring issues associated with MCED for your organization or professional conference. 

Speakers and Topics

Speakers affiliated with this program are nationally recognized thought leaders with expertise in diverse aspects of this topic. When you complete the Session Request Form you can indicate your preference for a preferred speaker or topic area. Not sure? No problem, JCPH will work with you to develop your session and select an appropriate speaker.

Request a Session

To request a session for your organization or professional conference, review the brochure and complete the Session Request Form,  Based on the information provided, JCPH will work with you to customize an educational session that meets your needs. Limited to one session per organization per year. 


Archives of past sessions are available on Jefferson Digital Commons. Past sessions include

Multi-Cancer Early Detection: Supporting Patients and Providers in Navigating the New Paradigm
Evolution of Early Cancer Detection Technology: New Screening Tools
The Convergence of Personalized Medicine and Population Health, with the Advent of Multi-Cancer Early Detection

Funding support for this series has been provided by Grail.